A New Device Improves Signs and Symptoms of TMD.
Conclusions: After 6 months, the ELIBA device is able to significantly reduce TMD-associated myogenous pain and to promote the enhancement of sEMG/KNG values.
Practical Implications: ELIBA can be considered as a new device, potentially useful for head-neck pain relief in patients suffering from chronic TMD. In addition, its use promotes a muscles relaxation inducing freeway space increase. This characteristic makes it particularly useful for rehabilitation of patients with not enough space for construction of conventional orthotics or neuromuscular bites.
PMID: 31198477 [PubMed - in process]
Source: Pain Research and Management - Category: Anesthesiology Authors: Cattaneo R, Pietropaoli D, Cooper BC, Capparè D, Ortu E, Monaco A Tags: Pain Res Manag Source Type: research
More News: Anesthesiology | Brain | Chronic Pain | Dentistry | Monaco Health | Neurology | Pain | Pain Management | Rehabilitation | Study | Temporomandibular Disorders